Healy, Kelsey M.
Ritter, Jacob
Barr, Emily
Churchill, Jessica L.
Trasolini, Nicholas A.
Waterman, Brian R.
Reynolds, Alan W.
Funding for this research was provided by:
Wake Forest University
Article History
Accepted: 9 September 2024
First Online: 14 September 2024
Declarations
:
: Dr. Waterman reports personal fees from Arthrex, DePuy Mitek, FH Ortho, Sparta Biosciences and Vericel. Dr. Waterman reports stock or stock options with Kaliber AI, Sparta Biosciences and Vivorte. All other authors declare no competing interests.